Risk factors and risk prediction model for mucocutaneous separation in enterostomy patients: A single center

Yun Liu1, Hong Li1, Jin-Jing Wu1

  • 1Department of Reconstructive, Hand and Plastic Surgery, Zhejiang Chinese Medical University, Lishui Central Hospital, 289 Kuocang Road, Liandu District, Lishui 323000, Zhejiang Province, China.

PubMed
Abstract

Insights

This study developed a predictive model to identify patients at risk for mucocutaneous separation (MCS) after enterostomy. The model, incorporating factors like suture dislodgement and albumin levels, shows good accuracy for early MCS detection.

Area of Science:

  • Surgical Complications
  • Enterostomy Management
  • Predictive Modeling in Medicine

Background:

  • Mucocutaneous separation (MCS) is a frequent and morbid complication following enterostomy surgery.
  • Effective early identification of patients at risk for MCS is essential but current predictive models are limited.

Purpose of the Study:

  • To develop and validate a risk prediction model for mucocutaneous separation (MCS) in patients undergoing enterostomy.
  • To assess the clinical predictive accuracy of the developed MCS risk model.

Main Methods:

  • A cohort of 492 enterostomy patients (January 2019-March 2023) were analyzed.
  • Patients were categorized into MCS (n=110) and non-MCS (n=382) groups based on early postoperative outcomes.
  • Univariate, multivariate analyses, and ROC curve analysis were employed to identify predictors and evaluate model performance.

Main Results:

  • The overall incidence of postoperative MCS was 22.4%.
  • Independent predictors identified for MCS included suture dislodgement, low serum albumin, lower BMI, lower hemoglobin, intestinal rupture, incision infection, neoadjuvant therapy, stoma site, and elevated intra-abdominal pressure.
  • The final model demonstrated strong predictive performance with an Area Under the Curve (AUC) of 0.827 and good clinical utility.

Conclusions:

  • A robust prediction model for mucocutaneous separation in enterostomy patients has been successfully developed.
  • This model offers valuable clinical utility for the early detection and management of MCS, improving patient outcomes.